XML 17 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES          
Net income/(loss)     $ 2,123,264 $ 2,753,385 $ 2,967,218
Adjustment to reconcile net income/(loss) to net cash provided by/(used in) operating activities          
Change in derivative liabilities $ (1,729,997) $ (1,142,727) (1,758,413) (1,536,067)  
Intangible asset impairment 79,634 0 79,634 0  
Interest expense from derivative instruments     109,035 122,858  
Employee stock compensation     107,075 261,926  
Provision for doubtful accounts 29,639 (76,363) 26,252 (46,997) 130,346
Depreciation and amortization     321,292 173,294  
Changes in operating assets and liabilities          
Accounts receivable     817,348 613,130  
Prepaid expenses     79,967 (35,182)  
Other current assets     (3,016) 20,765  
Other assets     (48,361) 5,565  
Accounts payable and accrued expenses     (979,804) (55,041)  
Patent settlement liability     (112,500) (343,437)  
Deferred revenue     (1,446,290) (948,794)  
Net cash provided by/(used in) operating activities     (684,517) 985,405  
CASH FLOWS FROM INVESTING ACTIVITIES          
Purchase of property and equipment     (438,573) (107,348)  
Purchase of Acuity software     (552,403) 0  
Net cash (used in) investing activities     (990,976) (107,348)  
CASH FLOWS FROM FINANCING ACTIVITIES          
Repayments of notes payable     (150,000) (100,000)  
Proceeds/(repayments) from revolving line of credit     1,750,000 (1,100,000)  
Proceeds from exercise of stock options     45,000 0  
Principal repayment of capital lease obligation     (10,546) 0  
Net cash provided by/(used in) financing activities     1,634,454 (1,200,000)  
Effect of exchange rate changes on fixed and intangible assets     2,835 (12,850)  
Effect of exchange rate changes on cash and cash equivalents     (21,168) 12,076  
Net increase/(decrease) in cash and cash equivalents     (59,372) (322,717)  
Cash and cash equivalents at beginning of period     1,176,551 1,439,332 1,439,332
Cash and cash equivalents at end of period $ 1,117,179 $ 1,116,615 1,117,179 1,116,615 $ 1,176,551
Supplemental disclosures of cash flow information:          
Income taxes     1,035 1,194  
Interest     523,061 534,238  
Non-cash transactions:          
Notes payable issued in exchange for existing notes payable     0 350,000  
Restricted stock issuance/(forfeiture)     0 (2,834)  
Common stock issued for the purchase of Acuity software     500,000 0  
Capital expenditures funded by capital lease borrowing     $ 359,603 $ 0